日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis

对重组噬菌体溶菌素AP50-31和LysB4作为强效杀菌剂对抗炭疽杆菌的抗菌特性进行了表征

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-017-18535-z
Park, Sangjin; Jun, Soo Youn; Kim, Chang-Hwan; Jung, Gi Mo; Son, Jee Soo; Jeong, Seong Tae; Yoon, Seong Jun; Lee, Sang Yup; Kang, Sang Hyeon
微生物学
炭疽
AP50
发表日期：2018
文献求助 收藏

Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers

健康志愿者单次静脉注射噬菌体溶素候选药物SAL200后的药代动力学和耐受性研究

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.02629-16
Jun, Soo Youn; Jang, In Jin; Yoon, Seonghae; Jang, Kyungho; Yu, Kyung-Sang; Cho, Joo Youn; Seong, Moon-Woo; Jung, Gi Mo; Yoon, Seong Jun; Kang, Sang Hyeon
发表日期：2017
文献求助 收藏

Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredient

对以重组噬菌体溶素SAL-1为药物成分的静脉注射制剂SAL200进行临床前安全性评价

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.02232-13
Jun, Soo Youn; Jung, Gi Mo; Yoon, Seong Jun; Choi, Yun-Jaie; Koh, Woo Suk; Moon, Kyoung Sik; Kang, Sang Hyeon
发表日期：2014
文献求助 收藏